What Opportunities for Orphan Drugs Exist in Specialty Pharmacy?

In this video, Gordon Vanscoy, PharmD, MBA, explains how policy changes and science have allowed orphan drugs to enter the specialty pharmacy market and create hope for patients.

In this video, Gordon Vanscoy, PharmD, MBA, explains how policy changes and science have allowed orphan drugs to enter the specialty pharmacy market and create hope for patients.

Transcript

"Orphan drugs presented a tremendous opportunity and it was really all created because of policy changes. The Orphan Drug Act, The Pediatric Voucher Act, really stimulated the opportunity for manufactures to bring more products to market and that stimulation obviously advanced the science, and policy and science together created a significant increase in the number of orphan products that came to market. So, the opportunity that we had was is being able to see this happen and see that it occurred, and orphan products end up being a significant part of specialty products. So, these babies, these adults, these individuals that we’re treating are individuals with not only rare but devastating disease states and it’s so rewarding to be able to bring something to them where they’ve never had hope before."